Southern California

Looking for a biotech job in San Diego? Check out these seven top companies hiring life sciences professionals like you.
Amgen has quietly discontinued the development of its Phase I bispecific T-cell engager AMG 794, which the company had been studying for several malignant solid tumors.
PRESS RELEASES